EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Evaluation of VYC ‐17. 5L for the Treatment of Marionette Lines: A Prospective, Open‐Label, Postmarketing Study

Sofia Ruiz Del Cueto, Fernando Urdiales Galvez iD, Alessandro Gritti, Nicola Kefalas, Carola de la Guardia, Graeme Kerson

Journal of Cosmetic Dermatology · 2025

DOI: 10.1111/jocd.16694 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Sofia Ruiz Del Cueto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clínica Mira and Cueto, Madrid, Spain. Hauptthemen laut MEDLINE: Hyaluronic Acid, Dermal Fillers, Skin Aging, Lidocaine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AbbVie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Marionette lines are a feature of the aging face, descending from the oral commissures towards the jaw. VYC‐17.5 L is a dermal filler that contains 17.5 mg/mL of hyaluronic acid (HA) and lidocaine (3 mg/mL); it is intended for the treatment of skin depressions. VYC‐17.5 L has been shown to be safe and effective in different conditions, but there is a lack of published literature on its effectiveness in marionette lines.

Aims

This 12‐month prospective, open‐label, post‐marketing study evaluated the effectiveness and safety of the injectable HA filler VYC‐17.5 L for the improvement of marionette lines.

Methods

Adults (≥ 18 years) with mild‐to‐severe marionette lines on the validated Allergan Marionette Line Scale (AMLS) received VYC‐17.5 L on Day 1 with optional touch‐up on Day 14. The primary endpoint was proportion of participants with ≥ 1‐point change in AMLS from baseline at Month 1 (M1). Secondary endpoints were investigator‐ and participant‐rated Global Aesthetic Improvement Scale (GAIS), FACE‐Q satisfaction with facial appearance, and appraisal of lines: marionette. Safety was assessed throughout.

Results

A total of 83 participants completed the study; 69.9% of participants had ≥ 1‐point change in AMLS at M1. Investigator and participant GAIS showed improvement. Both FACE‐Q scores significantly improved from baseline ( p < 0.0001). A significant volume improvement was seen and maximized at M1. Most participant‐reported injection site reactions were mild or moderate and resolved within 8 days; 14 subjects reported adverse device effects, with the most common being pain, which resolved within 8 days.

Conclusion

This prospective, open‐label study showed that VYC‐17.5 L effectively improved marionette lines and was well tolerated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronic AcidDermal FillersSkin AgingLidocaineCosmetic TechniquesHumansProspective StudiesFemaleMaleMiddle AgedProduct Surveillance, PostmarketingAdultTreatment OutcomeAgedPatient Satisfaction

Stichwörter der Autor:innen

VYC‐17.5 Lfacial wrinkleshyaluronic acidmarionette linesoral commissures

Substanzen

Hyaluronic AcidDermal FillersLidocaine

Autor:innen und Institutionen

  • Clínica Mira and Cueto, Madrid, Spain.
  • Instituto Médico Miramar, Málaga, Spain.
  • GRITTI Chirurgia Maxillo Facciale, Milan, Italy.
  • Private Practice, Torino, Italy.
  • Allergan Aesthetics, an AbbVie Company, Madrid, Spain.
  • Allergan Aesthetics, an AbbVie Company, Bucks, UK.

ORCID-Profile: Fernando Urdiales Galvez

Förderung

  • AbbVie

Zitieren

APA

Cueto, S. R. D., Urdiales Galvez, F., Gritti, A., Kefalas, N., de la Guardia, C., & Kerson, G. (2025). An Evaluation of VYC ‐17. 5L for the Treatment of Marionette Lines: A Prospective, Open‐Label, Postmarketing Study. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16694

Vancouver

Cueto SRD, Urdiales Galvez F, Gritti A, Kefalas N, de la Guardia C, Kerson G. An Evaluation of VYC ‐17. 5L for the Treatment of Marionette Lines: A Prospective, Open‐Label, Postmarketing Study. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.16694

BibTeX
@article{Cueto2025,
  author = {Cueto, Sofia Ruiz Del and Urdiales Galvez, Fernando and Gritti, Alessandro and Kefalas, Nicola and de la Guardia, Carola and Kerson, Graeme},
  title = {An Evaluation of VYC ‐17. 5L for the Treatment of Marionette Lines: A Prospective, Open‐Label, Postmarketing Study},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  doi = {10.1111/jocd.16694}
}
Kostenlos starten →